Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Metric	GILDGilead Sciences	AMGNAmgen	VRTXVertex Pharmaceuticals
Snapshot
Price	$149.70	$438.77	$554.15
Market cap	$162.98B	$201.93B	$115.02B
Valuation
P/E	20x	30.6x	28.7x
Forward P/E	14.3x	23.3x	27x
Growth
Revenue growth	3.5%	9.1%	10.1%
EPS growth	55.5%	31.3%	6.1%
Profitability
Net margin	31.0%	21.0%	35.5%
ROE	42.2%	89.4%	23.9%
Balance sheet & cash
Debt / equity	1.1x	6.31x	0.01x
Free cash flow yield	5.2%	6.0%	3.1%
Dividend yield	2.6%	2.9%	—
Verdict
Investment rating	Strong· 74	Favorable· 62	Favorable· 67

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

Year	GILDtoday $150	AMGNtoday $439	VRTXtoday $554
2027	$174.58 – $256.05+71% CAGR	$431.98 – $633.57+44% CAGR	$441.05 – $646.87+17% CAGR
2028	$271.45 – $398.12+63% CAGR	$567.06 – $831.69+38% CAGR	$468.04 – $686.46+11% CAGR
2029	$422.08 – $619.04+61% CAGR	$744.38 – $1,091.76+36% CAGR	$496.68 – $728.47+10% CAGR
2030	$656.29 – $962.55+59% CAGR	$977.15 – $1,433.15+34% CAGR	$527.08 – $773.05+9% CAGR
2031	$1,020.46 – $1,496.67+58% CAGR	$1,282.70 – $1,881.30+34% CAGR	$559.34 – $820.36+8% CAGR
5-yr CAGR	46.8% – 58.5%	23.9% – 33.8%	0.2% – 8.2%